Arcosa, Inc. is 3.4x more valuable than Proto Labs Inc by market capitalization ($6.03 B vs $1.77 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACA | PRLB |
|---|---|---|
| Market cap | $6.03 B | $1.77 B |
| US-listed rank | #1261 | #2189 |
| Revenue (latest FY) | $2.88B | $344.49M |
| Net income (latest FY) | $208.40M | $21.24M |
| Net margin | 7.2% | 6.2% |
| P/E (trailing FY) | 28.9 | 83.4 |
| SEC filings | 632 | 878 |
Arcosa, Inc. is 3.4x more valuable than Proto Labs Inc by market capitalization ($6.03 B vs $1.77 B).
In their latest fiscal years, Arcosa, Inc. reported $2.88B in revenue while Proto Labs Inc reported $344.49M.
Full pages: Arcosa, Inc. and Proto Labs Inc, or browse the full rankings.